Edwards Lifesciences Corporation
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$86Mgeneral payments (2019-2025)
$1.2Mresearch payments (2019-2025)
55,528clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Edwards Sapien 3 Transcatheter Heart Valve (Thv) $17M associated (2023-2025)
- Sapien 3 Ultra Resilia $3.7M associated (2023-2025)
- Pascal $2.7M associated (2023-2025)
- Edwards Sapien 3 Ultra Transcatheter Heart Valve $2.4M associated (2023-2025)
- Evoque $1.4M associated (2023-2025)
- Mitris Resilia Mitral Valve $706K associated (2023-2025)
- Hemosphere $528K associated (2023-2025)
- Inspiris Resilia Aortic Valve $392K associated (2023-2025)
- Konect Resilia $179K associated (2023-2025)
- The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System $155K associated (2023-2025)
- Edwards Sapien Xt Transcatheter Heart Valve (Thv) $21K associated (2023-2025)
- Edwards Intuity Elite Valve System $20K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Anthony Nunez | Orlando, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $4,784,987.15 |
| Augustin Delago | Albany, NY | Cardiovascular Disease | $1,157,022.27 |
| Kamran Muhammad | Tulsa, OK | Interventional Cardiology | $1,019,030.51 |
| Joseph Bavaria | Allentown, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $1,004,214.48 |
| Keith Allen | Kansas City, KS | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $977,628.24 |
| Nicolas Chronos | Eatonton, GA | Cardiovascular Disease | $907,417.31 |
| Quang Bui | Philadelphia, PA | Cardiovascular Disease | $897,203.54 |
| Andrei Pop | Elk Grove Village, IL | Interventional Cardiology | $852,345.13 |
| Arshad Quadri | W. Hartford, CT | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $626,253.49 |
| Jeremiah Depta | Milwaukee, WI | Internal Medicine | $607,981.36 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.